ChinaCureLinkJul 18 min readCasesCAR-T Treatment in China for Rare Intestinal T-Cell Lymphoma (MEITL): A Case Study
ChinaCureLinkJun 3011 min readBlogCAR-T Therapy in China for Indonesian Patients: The Complete Guide to CAR-T Treatment Indonesia Options
ChinaCureLinkJun 3011 min readBlogCAR-T Treatment Malaysia: The Complete 2026 Guide to Accessing Advanced Cell Therapy in China
ChinaCureLinkJun 2910 min readBlogCAR-T Therapy in China for Australian Patients: 7 Critical Facts That Could Change Your Treatment Decision in 2026
ChinaCureLinkJun 2910 min readBlogCAR-T Therapy in China: The Complete 2026 Guide for New Zealand Patients Who've Run Out of Options at Home
ChinaCureLinkJun 2413 min readBlogMultiple Myeloma in China 2026: Domestic BCMA CAR-T Delivers 64% 12-Month PFS
ChinaCureLinkJun 249 min readCasesRelapsed T-Cell Leukemia, CD7 CAR-T Therapy, and a Second Chance in China
ChinaCureLinkJun 2312 min readBlogIs China Effective at Treating Leukemia? Domestic CAR-T Reaches Up to 92% Response in Refractory B-ALL
ChinaCureLinkJun 2312 min readBlog2026 Breakthrough: China's CAR-T for Advanced Lymphoma Reaches 79%+ Response Rate
ChinaCureLinkJun 227 min readBlogIs China's Stem Cell Therapy for Type 2 Diabetes Effective? How Regenerated Islet Cells May Restore Insulin Production
ChinaCureLinkJun 2210 min readCasesDual-Target CAR-T Cell Therapy for Refractory and Relapsed Burkitt Lymphoma: A Five-Year Survival Case Study in China
ChinaCureLinkJun 1910 min readCasesNine Years, One Leap: How Multiple Myeloma Led an Italian Woman to CAR-T Therapy in China
ChinaCureLinkJun 187 min readCasesRefractory AML, One Last Option: How a Bone Marrow Transplant in China Brought a Young Husband Back to Life
ChinaCureLinkJun 178 min readBlogKidney Failure Treatment Options in 2026: Beyond Dialysis and Transplant
ChinaCureLinkJun 178 min readCasesPediatric Leukemia Case: Acute Lymphoblastic Leukemia Treated with Individualized Chemotherapy in China
ChinaCureLinkJun 1515 min readCasesRare MEITL Diagnosis, No Local Targeted Therapy: How One Canadian Patient Found a Treatment Path Through China's Top Hematology Hospital - A Case Study